5456-89-3

Basic information

• Product Name: [(E)-(4-methylphenyl)diazenyl]propanedinitrile
• CAS NO: 5456-89-3
• Molecular Formula: C₁₀H₈N₄
• Molecular Weight: 184.1973
• Mol File: 5456-89-3.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 287.5°C at 760 mmHg
• Flash Point: 127.7°C
• Density: 1.1g/cm³
• Vapor Pressure: 0.00248mmHg at 25°C
• Refractive Index: 1.582
• CAS DataBase Reference: [(E)-(4-methylphenyl)diazenyl]propanedinitrile(CAS DataBase Reference)
• NIST Chemistry Reference: [(E)-(4-methylphenyl)diazenyl]propanedinitrile(5456-89-3)
• EPA Substance Registry System: [(E)-(4-methylphenyl)diazenyl]propanedinitrile(5456-89-3)

Safety Data

• Hazardous Substances Data: 5456-89-3(Hazardous Substances Data)

Usage

General Description

[(E)-(4-methylphenyl)diazenyl]propanedinitrile is a chemical compound with the molecular formula C11H9N5. It is a diazo compound, which means it contains a diazenyl group (-N=N-). [(E)-(4-methylphenyl)diazenyl]propanedinitrile is often used in organic synthesis as a reagent for the formation of carbon-carbon bonds. It is also known for its vibrant yellow to orange color, which makes it useful as a dye or pigment in the production of various materials. Additionally, [(E)-(4-methylphenyl)diazenyl]propanedinitrile has been studied for its potential biological properties and has shown some promising antimicrobial and anticancer activities in preliminary research. However, further studies are necessary to fully understand its potential applications in medicine and other fields.

Upstream product

• 106-49-0 p-toluidine 
• 109-77-3 malononitrile 
• 2028-84-4 p-methylbenzenediazonium chloride 

Downstream Products

• 1261068-00-1 C₂₆H₁₇N₇O₅ 
• 1309877-30-2 4-(4-methylphenylazo)-3,5-diacetamido-1H-pyrazole 
• 118-70-7 4,5,6-triaminopyrimidine 
• 1316194-38-3 C₂₁H₁₆N₄OS 
• 1316194-30-5 C₂₅H₁₆N₄OS 
• 114275-57-9 2,5-Diamino-7-(4-methoxy-phenyl)-3-p-tolylazo-pyrazolo[1,5-a]pyrimidine-6-carbonitrile 
• 114275-54-6 2,5-Diamino-7-(4-chloro-phenyl)-3-p-tolylazo-pyrazolo[1,5-a]pyrimidine-6-carbonitrile 
• 114275-51-3 2,5-Diamino-7-phenyl-3-p-tolylazo-pyrazolo[1,5-a]pyrimidine-6-carbonitrile 
• 114299-70-6 1,3-Diphenyl-7-p-tolylazo-1H-pyrazolo[5,1-c][1,2,4]triazol-6-ylamine 
• 114275-73-9 7-Amino-4-phenyl-8-p-tolylazo-pyrazolo[5,1-c][1,2,4]triazine-3-carbonitrile 
• 114275-76-2 7-Amino-4-methyl-8-p-tolylazo-pyrazolo[5,1-c][1,2,4]triazine-3-carboxylic acid ethyl ester 
• 114275-48-8 7-Amino-9-p-tolylazo-1,3,4,5-tetrahydro-1,4a,4b,8-tetraaza-fluoren-2-one 
• 114299-69-3 4,7-Diamino-8-p-tolylazo-pyrazolo[5,1-c][1,2,4]triazine-3-carbonitrile 
• 114299-68-2 2-Amino-7-oxo-3-p-tolylazo-4,7-dihydro-pyrazolo[1,5-a]pyrimidine-6-carbonitrile 

Relevant articles and documents

Synthesis and Pharmacological Investigations of Novel Pyrazolyl and Hydrazonoyl Cyanide Benzimidazole Entities

Various novel benzimidazole entities linked to pyrazolyl and hydrazonoyl cyanide substrates carrying aryl and heteroaryl groups (8a–e to 10a–e) were synthesized using new route syntheses and were focused on their pharmacological evaluation as one of the m

Adenine intermediate pyrimidine-azo compound and preparation method thereof

The invention relates to an adenine intermediate pyrimidine-azo compound and a preparation method thereof. The preparation method comprises the following steps of: 1) dissolving primary amine in mixed-acid solution, dripping sodium nitrite solution to prepare diazonium salt shown in a formula (3), adding malononitrile for dissolving, and dripping alkaline solution to regulate a pH value of reaction solution and generate coupling reaction, thereby obtaining an intermediate pyrimidine-azo compound (4); 2) adding the intermediate pyrimidine-azo compound (4) prepared in the step 1) into formamide, introducing liquid ammonia, and heating to carry out high-temperature condensation and cyclization reaction, thereby obtaining an adenine intermediate pyrimidine-azo compound (5), wherein a series of derivatives of the adenine intermediate pyrimidine-azo compound can be prepared by selecting different primary amines. The adenine intermediate pyrimidine-azo compound and the preparation method have the advantages that water is used as a solvent in the step 1), and the solvent used in the step 2) can be repeatedly used, so that the 'three wastes' are fewer, and the environment-friendly effect is achieved; and the cost is low, so that the industrialization is easy and the economic benefit is obvious.

Synthesis and characterization of Ni(II) and Cd(II) complexes of 4-(4-nitrophenylazo)- 1H-pyrazole-3,5-diamine and 4-(4-methylphenylazo)-1H- pyrazole-3,5-diamine

In this study, the diazotized p-nitroaniline and p-methylaniline were coupled with malononitrile. The ring closure reaction of the obtained products with hydrazine monohydrate yielded 4-(4-methylphenylazo)-1H-pyrazole-3,5-diamine (L1) and 4-(4-nitrophenylazo)-1H-pyrazole- 3,5-diamine (L 2). The structure of the ligands has been elucidated by spectroscopic analyses. Then, novel Ni(II) and Cd(II) complexes of the ligands have been synthesized and the structures of these complexes determined by elemental analysis, spectrometric and TGA/DTA methods, molar conductance and magnetic susceptibility measurements. All the complexes were monomeric and diamagnetic. From the elemental analyses and mass spectra data, the complexes were proposed to the formulae [Ni2(L1)2(OH) 2]·2Cl·8.5H2O, [Cd2(L 1)2(OH)2]·2Cl·DMF·3H2O, [Ni(L2)2]·2Cl·2DMF·7H2O and [Cd2(L2)2(OH)2(H 2O)4]·2Cl·1.5H2O. For the Cd(L2) complex octahedral geometry was proposed, but the Ni(L 1), Ni(L2) and Cd(L1) complexes show four coordinated structure. The Ni(L1), Cd(L1) and Cd(L 2) complexes were found to be dinuclear. On the other hand the Ni(L2) complex was found to be mononuclear. All the complexes were found to be (1:2) electrolytes.